Scandinavian ChemoTech AB Series B
Research Scandinavian ChemoTech AB Series B (CMOTEC-B) on Bullrun: market cap SEK 96.21M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCMOTEC-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 96.21M
- Financial periodQ1 2026
- RevenueSEK 2.80M
- Net income-SEK 1.57M
- Free cash flow-SEK 1.14M
- Gross margin86.8%
Valuation Snapshot
latest market cap is SEK 96.21M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 12.29M | -SEK 8.06M | -SEK 3.74M | 83.8% | -0.33 | SEK 3.67M | SEK 0 | SEK 3.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-01 | SEK 96.21M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Scandinavian ChemoTech AB Series B
Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scandinavian ChemoTech AB Series B's market cap?
Scandinavian ChemoTech AB Series B's market capitalization is SEK 96.21M.
What does Scandinavian ChemoTech AB Series B do?
Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026. The company was incorporated in 2013 and is headquartered in Lund, Sweden.